Tower Research Capital (TRC)’s Celularity CELU Stock Holding History
Bought
Maintained
Sold
Other funds holding CELU
Tower Research Capital (TRC)'s CELU Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its Celularity (CELU) stake by 35% in Q3 2026, selling an estimated $1.81K and leaving 3,323 shares worth $4.49K. The position accounts for ﹤0.01% of the portfolio, ranked #4741.
Tower Research Capital (TRC) first reported a position in CELU in Q2 2020 and has held it in 21 quarters since. The position peaked at $51K in Q2 2022. 33 funds tracked by Wall St. Rank hold CELU as of Q3 2026.
- Tower Research Capital (TRC) held 3,323 shares of Celularity worth $4.49K as of Q3 2026.
- Tower Research Capital (TRC) sold 1,788 Celularity shares in Q3 2026, an estimated $1.81K.
- Celularity made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4741 holding.
- Tower Research Capital (TRC) first reported a position in Celularity in Q2 2020 and has held it in 21 quarters since.
- Tower Research Capital (TRC)'s Celularity position peaked at $51K in Q2 2022.
- 33 funds tracked by Wall St. Rank held Celularity as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.